<DOC>
	<DOCNO>NCT00002722</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug give high dos may kill tumor cell . PURPOSE : Randomized phase II trial study effectiveness high-dose chemotherapy treat patient advanced stomach cancer .</brief_summary>
	<brief_title>High-Dose Chemotherapy Treating Patients With Advanced Stomach Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine response rate patient advanced gastric cancer treat high-dose fluorouracil ( 5-FU ) v without high-dose leucovorin ( CF ) vs high-dose 5-FU/CF/cisplatin . II . Determine toxic effect regimens patient . III . Assess symptomatic improvement patient treat regimen . OUTLINE : This randomize , multicenter study . Patients stratify accord participate center , WHO performance status ( 0 1 v 2 ) , disease stage ( metastatic v locally advance ) . Patients randomize 1 3 treatment arm . Arm I : Patients receive fluorouracil ( 5-FU ) IV 24 hour weekly 6 week . Arm II : Patients receive leucovorin calcium ( CF ) IV 2 hour follow 5-FU IV 24 hour weekly 6 week . Arm III : Patients receive CF 5-FU arm II cisplatin IV 1 hour day 1 , 15 , 29 . Treatment repeat every 7 week maximum 4 course absence unacceptable toxicity disease progression . Patients follow every 8 week . PROJECTED ACCRUAL : A total 65-135 patient ( 21-45 per arm ) accrue study .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm gastric cancer either metastatic locally advanced inoperable Bidimensionally measurable disease No CNS metastasis PATIENT CHARACTERISTICS : Age : 75 Performance status : WHO 02 Life expectancy : At least 3 month Hematopoietic : Granulocyte count least 2,000/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 1.7 mg/dL Renal : Creatinine great 1.3 mg/dL Creatinine clearance great 60 mL/min Cardiovascular : No myocardial infarction within past 12 month No coronary heart disease require drug therapy Congestive heart failure arrhythmia treatable standard medication allow Other : No active infection No history severe mental disorder No malignancy within past 10 year except carcinoma situ cervix nonmelanoma skin cancer Not pregnant PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>stage III gastric cancer</keyword>
	<keyword>stage IV gastric cancer</keyword>
</DOC>